The effect of protein and blood cells on the flow-pressure characteristics of shunts.
It has long been assumed that a high cerebrospinal fluid protein concentration adversely affects the performance of shunts. There is little experimental evidence to support this viewpoint, however, and the few reports that have been published can be criticized for poor experimental design or presentation of results. A flow-dependent shunt perfusion model was constructed. PS Medical Flow Control valves (PS Medical Corporation, Goleta, CA) and Cordis-Hakim valves (Cordis Corporates, Miami, FL) were perfused with saline-plasma solutions in concentrations from 0 to 9 g/L of protein. Blood suspensions in dilutions from 0.25 to 1% were also studied. The opening and closing pressures of the valves were measured with a simple manometer, and the physical properties of the solutions were studied. The results indicated that the valves performed within the ranges specified by their manufacturers, even with markedly increased protein concentrations in the perfusate. Furthermore, the valve opening and closing pressures were lower with the protein-containing solutions than with the control solutions. Thus, the protein did not impair shunt function and we conclude that shunts can be inserted into patients who have elevated cerebrospinal fluid protein contents. However, blood cells did adversely affect performance and, therefore, patients with hemorrhagic cerebrospinal fluid should not receive shunts.
Brydon
H L
HL
Department of Neurosurgery, Great Ormond Street Hospital for Children, London, England.
Bayston
R
R
Hayward
R
R
Harkness
W
W
D015170:Cerebrospinal Fluid Pressure / Q000502:physiology*; D002556:Cerebrospinal Fluid Proteins / Q000502:physiology*; D002557:Cerebrospinal Fluid Shunts / Q000295:instrumentation*; D004867:Equipment Design; D004868:Equipment Failure; D004906:Erythrocyte Count; D006801:Humans
D002556:Cerebrospinal Fluid Proteins